DB, MD's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.comuser/130131/comments http://seekingalpha.com/article/79266/comments?source=feed#comment-176551 176551
You have drug reps flooding physician offices pushing one "me-too" after another. This is a recipe for disaster when the industry chooses to reinvest into marketing crap and into being the largest lobby in Washington rather than on truly innovating. More money is likely spent on lawyers fighting expiration of patents than on problem-solving, as this adds more to the bottom line.]]> Fri, 30 May 2008 08:16:25 -0400
You have drug reps flooding physician offices pushing one "me-too" after another. This is a recipe for disaster when the industry chooses to reinvest into marketing crap and into being the largest lobby in Washington rather than on truly innovating. More money is likely spent on lawyers fighting expiration of patents than on problem-solving, as this adds more to the bottom line.]]> http://seekingalpha.com/article/79266/comments?source=feed#comment-176204 176204 Thu, 29 May 2008 14:57:03 -0400 http://seekingalpha.com/article/64209/comments?source=feed#comment-116110 116110 1. Just because it lowers cholesterol, does it mean it will lower mortality? The bar for all anti-cholesterol meds will likely be set higher after the ENHANCE trial
2. Just because it' lowers it better than the rest, does it mean it will do well? Crestor languishes in the face of a much older Lipitor?
3. Is it safe? Tough question to answer at this early stage in the game.
4. Will FDA approve it? Will it be fast enough? Will it require more studies?
5. It is a crowded field and it is unclear to me at least, as a physician, that another me-too drug even if slightly more effective will result in a monumental prescription writing shift away from the more established meds.

Thoughts?]]> Wed, 13 Feb 2008 13:17:00 -0500 1. Just because it lowers cholesterol, does it mean it will lower mortality? The bar for all anti-cholesterol meds will likely be set higher after the ENHANCE trial
2. Just because it' lowers it better than the rest, does it mean it will do well? Crestor languishes in the face of a much older Lipitor?
3. Is it safe? Tough question to answer at this early stage in the game.
4. Will FDA approve it? Will it be fast enough? Will it require more studies?
5. It is a crowded field and it is unclear to me at least, as a physician, that another me-too drug even if slightly more effective will result in a monumental prescription writing shift away from the more established meds.

Thoughts?]]>